Mucositis and non-invasive markers of small intestinal function

Cancer Biology and Therapy

Volumn 8, Issue 9, 2009, Pages 753-758

  Tooley, Katie L ^a   Howarth, Gordon S ^a   Butler, Ross N ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

13C sucrose breath test; Intestinal permeability; Mucositis; Non invasive assessment; Small intestine

Indexed keywords

ANTINEOPLASTIC AGENT; CARBON 13; CITRULLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; IRINOTECAN; METHOTREXATE; SUCRASE;

ADVERSE DRUG REACTION; BREATH ANALYSIS; CHEMOTHERAPY INDUCED MUCOSA INFLAMMATION; ENZYME ACTIVITY; HUMAN; HYDROGEN BREATH TEST; INTESTINE MUCOSA PERMEABILITY; MUCOSA INFLAMMATION; NONHUMAN; REVIEW; SMALL INTESTINE DISEASE; SMALL INTESTINE MUCOSA; SMALL INTESTINE MUCOSA INFLAMMATION; SUCROSE BREATH TEST;

EID: 68149149804     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.9.8232     Document Type: Review

References (75)

1. Ijiri K, Potten CS. Response of intestinal cells of differing topographical and hierarchical status to ten cytotoxic drugs and five sources of radiation. Br J Cancer 1983; 47:175-85.
2. Mitchell EP, Schein PS. Gastrointestinal toxicity of chemotherapeutic agents. Semin Oncol 1982; 9:52-64.
3. Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 1998; 34:39-43.
4. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 2003; 98:1531-9.
5. Elting LS, Shih YC, Stiff PJ, Bensinger W, Cantor SB, Cooksley C, et al. Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stemcell transplant: analysis of phase 3 trial results. Biol Blood Marrow Transplant 2007; 13:806-13.
6. Huang E, Leung SW, Wang C, Chen H, Sun L, Fang F, et al. Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial. Int J Radiat Oncol Biol Phys 2000; 46:535-9.
7. McGuire D, Correa M, Johnson J, Wienandts P. The role of basic oral care and good clinical practice principles in the management of oral mucositis. Support Care Cancer 2006; 14:541-7.
8. Plevová. Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review. Oral Oncol 1999; 45:453-70.
9. Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004; 351:2590-8.
10. Ikuno N, Soda H, Watanabe M, Oka M. Irinotecan (CTP-11) and characteristic mucosal changes in the mouse ileum and cecum. J Natl Cancer Inst 1995; 87:1876-83.
11. Xian CJ, Couper R, Howarth GS, Read LC, Kallincos NS. Increased expression of HGF and c-met in rat small intestine during recovery from methotrexate-induced mucositis. Br J Cancer 2000; 82:945-52.
12. Keefe DMK, Cummins AG, Dale BM, Kotasek D, Robb TA, Sage RE. Effect of highdose chemotherapy on intestinal permeability in humans. Clin Sci 1997; 92:385-9.
13. Sonis ST, Elting LS, Keefe DMK, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004; 100:1995-2025.
14. Pico JL, Avila-Garavito A, Naccache P. Mucositis: its occurrence, consequences and treatment in the oncology setting. Oncologist 1998; 3:446-51.
15. Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 2007; 68:1110-20.
16. Heitlinger LA, Rossi TM, Lee P, Lebenthal E. Human intestinal disaccharidase activities: correlation with age, biopsy technique and degree of villus atrophy. J Pediatr Gastroenterol Nutr 1991; 12:204-8.
17. nd Edition. Philadelphia: B.C. Decker Inc 1996; 1576-91.
18. Adams HA, Pohlemann T. Effect of anesthetics on the function of the gastrointestinal tract. Anaesthesiol Reanim 1999; 24:88-94.
19. Sugahara S, Rosen M, Juniper CJ, Johnston KR, Davies RL. Effects of intrathecal and intraperitoneal morphine on gastrointestinal motility in the rat. Eur J Anaesthesiol 1992; 9:341-6.
20. Lembcke B, Schneider H, Lankisch PG. Is the assay of disaccharidase activity in small bowel mucosal biopsy relevant for clinical gastroenterologists? Klin Wochenschr 1989; 67:568-75.
21. Keefe DMK, Brealey J, Goland GJ, Cummins AG. Chemotherpay for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 2000; 47:632-7.
22. Menzies IS, Pounder R, Heyer S, Laker MF, Bull J, Wheeler PG, et al. Abnormal intestinal permeability to sugars in villous atrophy. Lancet 1979; 2:1107-9.
23. Pearson ADJ, Craft AW, Pledger JV, Eastham EJ, Laker MF, Pearson GL. Small bowel function in acute lymphoblastic leukaemia. Arch Dis Child 1984; 59:460-5.
24. Cummins AG, Penttila IA, Labrooy JT, Robb TA, Davidson GP. Recovery of the small intestine in coeliac disease on a gluten-free diet: changes in intestinal permeability, small bowel morphology and T-cell activity. J Gastroenterol Hepatol 1991; 6:53-7.
25. Bjarnason I, Macpherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995; 108:1566-81.
26. Kohout P, Cerman J, Brátová M, Zadák Z. Small bowel permeability in patients with cytostatic therapy. Nutrition 1999; 15:546-9.
27. Miki K, Butler R, Moore D, Davidson G. Rapid and simultaneous quantification of rhamnose, mannitol and lactulose in urine by HPLC for estimating intestinal permeability in pediatric practice. Clin Chem 1996; 42:1-5.
28. Haase AM, Kukuruzovic RH, Dunn K, Bright A, Brewster DR. Dual sugar permeability testing in diarrheal disease. J Pediatr 2000; 136:232-7.
29. Behrens RH, Lunn PG, Northrop CA, Hanlon PW, Neale G. Factors affecting the integrity of the intestinal mucosa of Gambian children. Am J Clin Nutr 1987; 45:1433-41.
30. Meddings JB, Sutherland LR, Byles NI, Wallace JL. Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology 1993; 104:1619-26.
31. Sutherland LR, Verhoef M, Wallace JL, van Rosendaal G, Crutcher R, Meddings JB. A simple, non-invasive marker of gastric damage: sucrose permeability. Lancet 1994; 343:998-1000.
32. Smecuol E, Bai JC, Vazquez H, Kogan Z, Cabanne A, Niveloni S, et al. Gastrointestinal permeability in celiac disease. Gastroenterology 1997; 112:1129-36.
33. Meddings JB, Gibbons I. Discrimination of site-specific alterations in gastrointestinal permeability in the rat. Gastroenterology 1998; 114:83-92.
34. Miki K, Moore DJ, Butler RN, Southcott E, Couper RTL, Davidson GP. The sugar permeability test reflects disease activity in children and adolescents with inflammatory bowel disease. J Pediatr 1998; 133:750-4.
35. Davies NM, Wright MR, Jamali F. Anti-inflammatory drug-induced small intestinal permeability: the rat is a suitable model. Pharm Res 1994; 11:1652-6.
36. Smecuol E, Bai JC, Sugai E, Vazquez H, Pedreira S, Maurino E, et al. Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs. Gut 2001; 49:650-5.
37. Playford RJ, MacDonald CE, Calnan DP, Floyd DN, Podas T, Johnson W, et al. Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability. Clin Sci 2001; 100:627-33.
38. Melichar B, Kohout P, Brátová M, Solichová D, Králícková P, Zadák Z. Intestinal permeability in patients with chemotherapy-induced stomatitis. J Cancer Res Clin Oncol 2001; 127:314-8.
39. Pledger JV, Pearson ADJ, Craft AW, Laker MF, Eastham EJ. Intestinal permeability during chemotherapy for childhood tumours. Eur J Pediatr 1988; 147:123-7.
40. Daniele B, Secondulfo M, De Vivo R, Pignata S, De Magistris L, Delrio P, et al. Effect of chemotherapy with 5-Fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer. J Clin Gastroenterol 2001; 32:228-30.
41. Bond JH Jr, Levitt MD, Prentiss R. Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements. J Lab Clin Med 1975; 85:546-55.
42. Van Wyk M, Sommers DK, Steyn AG. Evaluation of gastrointestinal motility using the hydrogen breath test. Br J Clin Pharmacol 1985; 20:479-81.
43. Tooley KL, Saxon BR, Webster J, Zacharakis B, McNeil Y, Davidson GP, et al. A novel non-invasive biomarker for assessment of small intestinal mucositis in children with cancer undergoing chemotherapy. Cancer Biol Ther 2006; 5:1275-81.
44. Teo M, Chung S, Chitti L, Tran C, Kritas S, Butler R, et al. Small bowel bacterial overgrowth is a common cause of chronic diarrhea. J Gastroenterol Hepatol 2004; 19:904-9.
45. Riordan SM, McIver CJ, Walker BM, Duncombe VM, Bolin TD, Thomas MC. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol 1996; 91:1795-803.
46. 2 breath test. Scand J Gastroenterol 1999; 34:35-40.
47. Bartram HP, Scheppach W, Gerlach S, Ruckdeschel G, Kelber E, Kasper H. Does yogurt enriched with Bifidobacterium longum affect colonic microbiology and fecal metabolites in health subjects? Am J Clin Nutr 1994; 59:428-32.
48. Bouhnik Y, Achour L, Paineau D, Riottot M, Attar A, Bornet F. Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers. Nutr J 2007; 6:42.
49. Shindo K, Machida M, Fukumura M, Koide K, Yamazaki R. Omeprazole induces altered bile acid metabolism. Gut 1998; 42:266-71.
50. Hyams JS, Batrus CL, Grand RJ, Sallan SE. Cancer chemotherapy-induced lactose malabsorption in children. Cancer 1982; 49:646-50.
51. Parnes HL, Fung E, Schiffer CA. Chemotherapy-induced lactose intolerance in adults. Cancer 1994; 74:1629-33.
52. Pinkus LM, Windmueller HG. Phosphate-dependent glutaminase of small intestine: localization and role in intestinal glutamine metabolism. Arch Biochem Biophys 1977; 182:506-17.
53. Wu G, Knabe DA, Flynn NE. Synthesis of citrulline from glutamine in pig enterocytes. Biochem J 1994; 299:115-21.
54. Wu G, Davis PK, Flynn NE, Knabe DA, Davidson JT. Endogenous synthesis of arginine plays an important role in maintaining arginine homeostasis in postweaning growing pigs. J Nutr 1997; 127:2342-9.
55. Rhoads JM, Plunkett E, Galanko J, Lichtman S, Taylor L, Maynor A, et al. Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome. J Pediatr 2005; 146:542-7.
56. Crenn P, Vahedi K, Lavergne-Slove A, Cynober L, Matuchansky C, Messing B. Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology 2003; 124:1210-9.
57. Gondolesi G, Fishbein T, Chehade M, Tschernia A, Magid M, Kaufman S, et al. Serum citrulline is a potential marker for rejection of intestinal allografts. Transplant Proc 2002; 34:918-20.
58. Gondolesi GE, Kaufman SS, Sansaricq C, Magid MS, Raymond K, Iledan LP, et al. Defining normal plasma citrulline in intestinal transplant recipients. Am J Transplant 2004; 4:414-8.
59. Lutgens LC, Blijlevens NM, Deutz NE, Donnelly JP, Lambin P, de Pauw BE. Monitoring myeloblative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests. Cancer 2005; 103:191-9.
60. Blijlevens NM, Lutgens LC, Schattenberg AV, Donnelly JP. Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy. Bone Marrow Transplant 2004; 34:193-6.
61. Lutgens LC, Deutz NE, Gueulette J, Cleutjens JP, Berger MP, Wouters BG, et al. Citrulline: a physiologic marker enabling quantitation and monitoring of epithelial radiation-induced small bowel damage. Int J Radiat Oncol Biol Phys 2003; 57:1067-74.
62. Lutgens LC, Blijlevens NM, Deutz NE, Donnelly JP, Lambin P, de Pauw BE. Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests. Cancer 2005; 103:191-9.
63. Ziegler TR. Glutamine supplementation in bone marrow transplantation. Br J Nutr 2002; 87:9-15.
64. Boukhettala N, Leblond J, Claeyssens S, Faure M, Le Pessot F, Bole-Feysot C, et al. Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake. Am J Physiol Endocrinol Metab 2009; 296:182-90.
65. Welsh JD, Poley JR, Bhatia M, Stevenson DE. Intestinal disaccharidase activities in relation to age, race and mucosal damage. Gastroenterology 1978; 75:847-55.
66. Gray GM, Conklin KA, Townley RR. Sucrase-isomaltase deficiency. N Engl J Med 1976; 294:750-3.
67. Pelton NS, Tivey DR, Howarth GS, Davidson GP, Butler RN. A novel breath test for the non-invasive assessment of small intestinal mucosal injury following methotrexate administration in the rat. Scand J Gastroenterol 2004; 39:1015-6.
68. 2 breath tests. Am J Clin Nutr 1980; 33:2375-85.
69. 2-breath tests. Janssens J, ed. Progress in understanding and management of gastro-intestinal motility disorders. Belgium: Katholieke Universiteit Leuven 1993; 169-80.
70. Clarke JM, Pelton NS, Bajka BH, Howarth GS, Read LC, Butler RN. Use of the sucrose breath test to assess chemotherapy-induced mucositis in the rat. Cancer Biol Ther 2006; 5:34-8.
71. Tooley KL, Howarth GS, Lymn K, Lawrence A, Butler RN. Oral ingestion of Streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate treated rats. Cancer Biol Ther 2006; 5:593-600.
72. Cool JC, Dyer JL, Xian CJ, Butler RN, Geier MS, Howarth GS. Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats. Growth Horm IGF Res 2005; 15:72-82.
73. Howarth GS, Tooley KL, Davidson GP, Butler RN. A non-invasive method for detection of intestinal mucositis induced by different classes of chemotherapy drugs in the rat. Cancer Biol Ther 2006; 5:1189-95.
74. Mauger CA, Butler RN, Geier MS, Tooley KL, Howarth GS. Probiotic effects on 5-fluorouracil-induced mucositis assessed by the sucrose breath test in rats. Dig Dis Sci 2007; 52:612-9.
75. Torres DM, Tooley KL, Butler RN, Smith CL, Geier MS, Howarth GS. Lyprinol™ only partially improves indicators of small intestinal integrity in a rat model of 5-fluorouracilinduced mucositis. Cancer Biol Ther 2007; 295-302.